EATON VANCE GROWTH TRUST
NSAR-B, EX-27, 2000-11-14
Previous: EATON VANCE GROWTH TRUST, NSAR-B, EX-27, 2000-11-14
Next: VARCO INTERNATIONAL INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 6
<SERIES>
   <NUMBER> 4
   <NAME> EATON VANCE WORLD WIDE HEALTH SCIENCES FUND - CLASS C
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-END>                               AUG-31-2000
<INVESTMENTS-AT-COST>                           613258
<INVESTMENTS-AT-VALUE>                          942964
<RECEIVABLES>                                    17654
<ASSETS-OTHER>                                      10
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                  960627
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                         1470
<TOTAL-LIABILITIES>                               1470
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                        580725
<SHARES-COMMON-STOCK>                             5594
<SHARES-COMMON-PRIOR>                             1889
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                          48750
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        329706
<NET-ASSETS>                                    128973
<DIVIDEND-INCOME>                                 1851
<INTEREST-INCOME>                                   36
<OTHER-INCOME>                                  (4352)
<EXPENSES-NET>                                    4683
<NET-INVESTMENT-INCOME>                         (7147)
<REALIZED-GAINS-CURRENT>                         54160
<APPREC-INCREASE-CURRENT>                       287478
<NET-CHANGE-FROM-OPS>                           334491
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                         11143
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                           5401
<NUMBER-OF-SHARES-REDEEMED>                      (509)
<SHARES-REINVESTED>                                 61
<NET-CHANGE-IN-ASSETS>                            4953
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                                0
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                   4710
<AVERAGE-NET-ASSETS>                             40091
<PER-SHARE-NAV-BEGIN>                            12.13
<PER-SHARE-NII>                                 (.356)
<PER-SHARE-GAIN-APPREC>                         12.708
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                      (1.423)
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              23.05
<EXPENSE-RATIO>                                   2.53


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission